Stelazine advertisement, 1961.|
Mental Hospitals, Vol. 12, No. 2.
Stelazine® brand of trifluoperazine should be tried in chronic schizophrenics
Clinical evidence shows that 'Stelazine' can produce significant improvement in at least 30%-40% of a given group of
chronic schizophrenics. Because of this demonstrated effectiveness, 'Stelazine' should be tried in chronic schizophrenics,
no matter how discouraging the results of previous therapies may have been -- no matter whether the patient is hyperactive,
withdrawn, or has delusions or hallucinations.
And it should be given at high enough dosages for long enough periods of time.
Smith, Kline & French Laboratories     SK&F     leaders in psychopharmaceutical research